Clinical trials: Type 1 Diabetes, completed
Diabetic Retinopathy
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
The study's main purpose is to asses the safety, tolerability, and effect of oral administration of RG7774 on the severity of diabetic retinopathy (DR) in participants with moderately severe to severe non-proliferative diabetic…
- Trial name
- CANBERRA (NCT04265261)
- Testing
- RG7774
- Where
- 68 sites in United States, Australia and 5 more
- Volunteers
- 139 people
- Sponsor
- Hoffmann-La Roche
Type 2 Diabetes Mellitus
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
To explore the mechanism of action of ranolazine as a potential treatment for type 2 diabetes mellitus (T2DM).
- Trial name
- NCT01843127
- Testing
- Ranolazine, Exenatide
- Where
- 3 sites in United States
- Volunteers
- 24 people
- Sponsor
- Gilead Sciences
Hypoglycemia
The SMART B Exercise Study :''The SMART Study''
Despite the established health benefits conveyed by physical activity for people with type 1 diabetes (T1D), participation rates remain low, with fear of hypoglycaemia, lack of freedom to engage in unplanned activities, and…
- Trial name
- SMART (NCT05133765)
- Testing
- Insulin pump
- Where
- Denmark
- Volunteers
- 11 people
- Sponsor
- Steno Diabetes Center Copenhagen
Diabetes Mellitus, Type 1
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will…
- Trial name
- NCT03534544
- Where
- 2 sites in United States
- Volunteers
- 362 people
- Sponsor
- Joslin Diabetes Center
Type 1 Diabetes, Hypoglycemia
Islet Allotransplantation With Steroid Free Immunosuppression
The restoration of endogenous insulin secretion carries significant hopes for shifting the paradigm of life long exogenous insulin therapy in selected groups of patients with type 1 diabetes(T1D).
- Conditions
- Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
- Trial name
- NCT00446264
- Testing
- islet transplantation, daclizumab - sirolimus - tacrolimus
- Where
- France
- Volunteers
- 14 people
- Sponsor
- University Hospital, Lille
Diabetes
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
The purpose of this study is to collect confirmatory clinical data to support 6 or 7 days wear of EWIS (Extended Wear Infusion Set).
- Trial name
- NCT04113694
- Testing
- Extended Infusion Set
- Where
- 15 sites in United States
- Volunteers
- 291 people
- Sponsor
- Medtronic MiniMed, Inc.
Diabetes Mellitus, Type 1
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
The trial is a randomized controlled, parallel group design study. Patients will be followed up during approximatively 12 months.
- Trial name
- NCT06236256
- Testing
- MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system, MDI/CSII
- Where
- Israel
- Volunteers
- 42 people
- Sponsor
- Sheba Medical Center
Diabetes Mellitus
Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus
10 type 1 diabetes, 10 type 2 diabetes and 10 healthy controls matched with age and sex were enrolled in our study and their periphera blood mononuclear cells (PBMC) were isolated.
- Trial name
- NCT03136939
- Testing
- No intervention
- Where
- China
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- First Affiliated Hospital of Zhejiang University
Type 1 Diabetes
Physical Activity and Glycemic Control in Adolescents
The purpose of this pilot study is to evaluate the initial efficacy of a reinforcement intervention to enhance physical activity levels in sedentary adolescents and young adults with type 1 diabetes (T1D).
- Trial name
- NCT02674828
- Testing
- Reinforcement for meeting targeted physical activity goals, Standard of Care
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Yale University
Type 1 Diabetes Mellitus
The Artificial Pancreas in Very Young Children With T1D
The suggested clinical trial is part of the KidsAP project funded by the European Commission's Horizon 2020 Framework Programme and JDRF.
- Trial name
- KidsAP02 (NCT03784027)
- Testing
- CamAPS FX, Sensor augmented therapy
- Where
- 8 sites in Austria, Germany and 2 more
- Volunteers
- 81 people
- Sponsor
- University of Cambridge
Type 1 Diabetes
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
The goal of this clinical trial is to assess the safety of a new U500 insulin formulation and to determine how rapidly it is absorbed and how long it takes to act when administered intraperitoneally.
- Trial name
- NCT07341373
- Testing
- Portal Insulin U-500, Humulin R U-500, Lyumjev U-100 Insulin
- Where
- United States
- Volunteers
- 29 people
- Sponsor
- Portal Diabetes, Inc.
Diabetes, Diabetes Mellitus, Type 1
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
This trial is conducted in Europe. The aim of this trial is to compare the pharmacodynamics and pharmacokinetics after a single dose of biphasic insulin aspart 30, biphasic insulin aspart 50, biphasic insulin aspart 70 and…
- Trial name
- NCT01536028
- Testing
- biphasic insulin aspart 30, biphasic insulin aspart 50, biphasic insulin aspart 70
- Where
- Germany
- Volunteers
- 32 people
- Sponsor
- Novo Nordisk A/S
Type 1 Diabetes
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
The purpose of this study is to evaluate the safety of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 pediatric subjects (2-6 years of age) in a home setting.
- Trial name
- SUCCEED2 (NCT06604871)
- Testing
- Insulin Pump with Continuous Glucose Monitoring
- Where
- 8 sites in United States
- Volunteers
- 56 people
- Sponsor
- Medtronic MiniMed, Inc.
Diabetes
Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
140 subjects will be enrolled into the clinical study and randomized into the Control Group or the Experimental Group by block randomization. The subjects must meet all inclusion and none of the exclusion criteria.
- Trial name
- NCT00552734
- Testing
- Insulin Guidance Software
- Where
- United States
- Volunteers
- 123 people
- Sponsor
- University of Colorado, Denver
Type1diabetes
The Impact of a Predictive Hypoglycaemia Alert Function in Physical Activity for People With T1DM
Observational, within-subject, crossover study To assess the impact of Dexcom G6 RT-CGM with a predictive hypoglycaemia alert function on the frequency, duration and severity of hypoglycaemia occurring before, during and after…
- Trial name
- PACE (NCT04142944)
- Testing
- Dexcom G6 with alert, Dexcom G6 without alert
- Where
- United Kingdom
- Volunteers
- 30 people
- Sponsor
- Imperial College London
Type 2 Diabetes Mellitus
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
This is a Phase 1, randomized, placebo-controlled, double-blind (investigator- and participant-blinded), sponsor-open study of PF-07081532.
- Trial name
- NCT05158244
- Testing
- PF-07081532
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Pfizer
Type 1 Diabetes Mellitus
Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus
Almost all patients with type 1 diabetes mellitus (T1DM) need insulin treatment permanently. For selected patients who are unable to achieve glycaemic targets with subcutaneous (SC) insulin treatment, continuous intraperitoneal…
- Trial name
- IPvsSC (NCT01621308)
- Testing
- Mode of insulin administration
- Where
- 2 sites in Netherlands
- Volunteers
- 190 people
- Sponsor
- Medical Research Foundation, The Netherlands
Diabetes Mellitus, Insulin-Dependent, Diabetes
The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes
The study RADAR aims at developing a wearable based dysglycemia detection and warning system for patients with diabetes mellitus using artificial intelligence.
- Trial name
- RADAR (NCT04689685)
- Testing
- Wearing smartwatch and continous glucose sensor
- Where
- Switzerland
- Volunteers
- 40 people
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Type 1 Diabetes Mellitus
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
The purpose of this research study is to find out ways to help pre-teens and teens and their families to improve diabetes control and to help with the burden of diabetes management.
- Trial name
- NCT01083433
- Testing
- Diabetes related psychological counseling and education, Continuous Glucose Monitor
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- University Hospitals Cleveland Medical Center
Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2)
Diabetes and Permanent Disabilities
This study examines permanent disability related to diabetes using routinely collected data from the National Insurance Institute of Israel.
- Trial name
- DIAB-PD (NCT07788235)
- Where
- 2 sites in Israel
- Volunteers
- 450,000 people
- Sponsor
- Assuta Medical Center
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.